Elehear Beyond Pro vs Otofonix Groove

The Elehear Beyond Pro is a mid-priced OTC hearing aid that earns an A grade with a SoundScore of 4.2/5 in our lab testing, placing it #11 out of 65 OTC devices tested. At $631, this behind-the-ear rechargeable device delivers strong overall performance and has earned HearAdvisor's Expert's Choice Award for both 2024 and 2025. In our testing, the Beyond Pro excels in music streaming, scoring 3.8/5—a solid result that sits 1.88 points above the OTC category average of 1.92/5. Speech clarity in quiet environments also performs well at 3.3/5, which is 0.46 points above average. Speech in noise scores 2.5/5, which is above the category average by 1.00 points, though this remains a mixed result in absolute terms. Feedback handling is excellent at a perfect 5.0/5. The primary limitation is own-voice comfort, which scores 1.2/5—a low result that falls 1.31 points below the category average. Users sensitive to hearing their own voice may find this more noticeable. The device uses closed domes with a medium-power receiver and achieved identical scores in both initial and tuned fit conditions in our testing. The Beyond Pro supports both iPhone and Android streaming with hands-free functionality. It's best suited for users who prioritize streaming audio quality and speech clarity and are less sensitive to own-voice occlusion effects. Within its price range, it competes with devices like the Sony CRE-E10 and Lexie B2 Plus, though some competitors in this tier score higher overall.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.